(Q54002942)

23 May 2018

title

Bioavailability Study of Menorest®, a New Estrogen Transdermal Delivery System, Compared with a Transdermal Reservoir System. (English)

1 reference

23 May 2018

1 reference

Y Le Roux

1

1 reference

23 May 2018

M L Borg

2

1 reference

23 May 2018

M Sibille

3

1 reference

23 May 2018

J Thebault

4

1 reference

23 May 2018

A Renoux

5

1 reference

23 May 2018

M J Douin

6

1 reference

23 May 2018

F Djebbar

7

1 reference

23 May 2018

M P Dain

8

1 reference

23 May 2018

publication date

1 September 1995

1 reference

23 May 2018

Clinical Drug Investigation

published in

1 reference

23 May 2018

volume

10

1 reference

23 May 2018

issue

3

1 reference

23 May 2018

page(s)

172-178

1 reference

23 May 2018

Increased risk of cholecystectomy in users of supplemental estrogen.

cites work

1 reference

12 December 2020

Kinetics and pharmacology of estrogens in pre- and postmenopausal women.

1 reference

12 December 2020

Biological Effects of Various Doses of Conjugated Equine Estrogens in Postmenopausal Women*

1 reference

12 December 2020

Current status and future prospects of transdermal estrogen replacement therapy

1 reference

12 December 2020

Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study

1 reference

12 December 2020

Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII

1 reference

12 December 2020

Pharmacology and pharmacokinetics of estrogens

1 reference

12 December 2020

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

1 reference

12 December 2020

Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints

1 reference

12 December 2020

Postmenopausal use of estrogen and occlusion of coronary arteries

1 reference

12 December 2020

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

12 December 2020

Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol.

1 reference

12 December 2020

Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial

1 reference

12 December 2020

Cyclic hormonal replacement therapy after the menopause: Transdermal versus oral treatment

1 reference

12 December 2020

Menopausal endocrinology and management

1 reference

12 December 2020

Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-Up Study

1 reference

12 December 2020

A comparison between effects of estradiol valerate and low dose ethinyl estradiol on haemostasis parameters

1 reference

12 December 2020

The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females

1 reference

12 December 2020

Postmenopausal estrogen use and coronary atherosclerosis

1 reference

12 December 2020

Transdermal estradiol. A potentially improved method of hormone replacement.

1 reference

12 December 2020

Long-term effects of transdermal estradiol with and without medroxyprogesterone acetate

1 reference

12 December 2020

A risk-benefit appraisal of transdermal estradiol therapy

1 reference

12 December 2020

Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center

1 reference

12 December 2020

Long-term estrogen replacement therapy prevents bone loss and fractures

1 reference

12 December 2020

10.2165/00044011-199510030-00006

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018